Exyte named as general contractor (EPCQ contract partner) Project is part of the German government's program to prepare for future pandemics Implementation in less than 24 months thanks to ExyCell modular system Lighthouse project for the strategic growth segment of Biopharma and Life Sciences at Exyte Biotechnology and personalized medicine drive growth Exyte CEO Bchele: "Better medical care, faster healing processes, a higher life expectancy - all this facilitated with the support of Exyte." STUTTGART, July 8, 2022 /PRNewswire/ Exyte GmbH (Exyte), a global leader in the design, engineering and delivery of facilities for high-tech industries, is building a mRNA competence center at the Halle Biotech site of Wacker Chemie AG (WACKER). The project is making a considerable contribution towards strengthening the Biopharma and Life Sciences segment at Exyte as well as to the company's ambitious "Pathway to Ten" growth path. Today, a breaking of ground ceremon
HEIDELBERG, Germany, March 24, 2022 / B3C newswire / The Federal Republic of Germany has announced its decision to sign contracts with Celonic AG and four other partners to secure the long-term supply of vaccines in Germany against Covid-19 and other pandemics. Celonic will provide the capacity and the expertise.
100 Days Mission: First Implementation Report - HTML gov.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gov.uk Daily Mail and Mail on Sunday newspapers.